Because apoptotic death plays a critical role in cardiomyocyte loss during ischaemic heart injury, a detailed understanding of the mechanisms involved is likely to have a substantial impact on the optimization and development of treatment strategies. The goal of this study was to assess gene profiling during ischaemia/hypoxia and to evaluate the functions of ischaemia/hypoxia-responsive genes in in vivo and in vitro ischaemia/hypoxia-induced cardiomyocyte apoptosis models.
Introduction
Apoptotic death plays a critical role in cardiomyocyte loss during ischaemic heart diseases, including acute myocardial infarction (MI). 1 Rat models of MI have been extensively used for further understanding of the functional, structural, and molecular changes associated with ischaemic heart diseases, and recent studies have emphasized the negative role played by cardiomyocyte apoptosis in cardiac function and have demonstrated a causal relationship between cardiomyocyte apoptosis and ischaemic heart disease. 2 Millions suffer from ischaemic heart diseases, and many of them develop heart failure and subsequent progressive disease, despite advances in pharmacological therapy. 3 Therefore, knowledge of the apoptotic mechanisms involved is likely to benefit the developments of suitable therapeutic strategies.
Recent technological advances in the production of cDNA microarrays make it possible to profile the expressions of thousands of genes simultaneously. 4 Furthermore, information regarding the upand down-regulations of genes in response to specific stimuli provides insights of the underlying molecular bases of responses to these stimuli and of gene function. However, although a number of genes have been found to be differentially expressed genes in animal models of MI 5 and in cardiomyocyte models of hypoxia 6 using DNA microarrays, the roles played by these genes in ischaemia/ hypoxia-induced apoptotic death have not been fully evaluated. Accordingly, this study was conducted to identify novel genes responsive to an ischaemic/hypoxic insult that participate in cardiomyocyte apoptosis. To assess gene profiling during ischaemia/ hypoxia, in vivo and in vitro models of transient ischaemia 7 were subjected to DNA microarray analysis and real-time polymerase chain reaction (PCR). In addition, using loss-of-function and gain-of-function techniques, we evaluated the functions of ischaemia/ hypoxia-responsive genes in in vivo and in vitro models of ischaemia/ hypoxia-induced cardiomyocyte apoptosis.
Methods

Rat ischaemic heart model
All protocols used conformed with the guidelines in the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH Publication No. 85-23, revised 1996) and were approved by the Committee on Animal Research at Ajou Medical Center, Ajou University, Suwon, Republic of Korea. Male SpragueDawley rats (250 -300 g) were anaesthetized with pentobarbital sodium (75 mg/kg, intraperitoneally) before surgery, and body temperatures were maintained at 37 + 0.58C throughout surgery using a thermostatically controlled warming plate. In each animal, the trachea was cannulated and ventilation was conducted using a Harvard Rodent Respirator (Model 683, Harvard Apparatus, Holliston, MA, USA) with a tidal volume of 1 mL/ 100 g and a frequency of 60 strokes/min. For microarray analysis, hearts were extirpated from rats immediately after 45 min of ischaemia which was induced by ligating the left anterior descending coronary artery (LAD) for 45 min. In loss-of-function study, ischaemia-induced myocardial injury was produced by ligating the LAD for 45 min followed by reperfusion for 24 h [for terminal dUTP nick end-labelling (TUNEL) assay] or 90 min (for infarct size measurement), as described previously. 8, 9 Ischaemia was confirmed by myocardial blanching and by electrocardiographic traces for evidence of injury. In sham animals, thoracotomy was performed without LAD ligation.
Cell culture and hypoxia in vitro
Neonatal rat ventricular cardiomyocytes were prepared from 1-or 2-day-old neonatal Sprague-Dawley rats using a standard protocol 10 with slight modification. Rat heart-derived H9c2 cell lines were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Both cell types were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5.5 mM glucose supplemented with 10% foetal bovine serum and 1% penicillin/streptomycin. To induce hypoxia, H9c2 cells were transferred into an anaerobic chamber maintained at 378C with humidified atmosphere of 5% CO 2 , 10% H 2 , and 85% N 2 , for several time points (15 min-8 h), as described previously. 10 In the anaerobic chamber, the culture medium was replaced with serum-free, glucosefree DMEM that had been saturated with N 2 gas for 40 min.
Microarray analysis
Total RNA was extracted from left ventricles (LVs) and neonatal rat cardiomyocytes after exposure to ischaemia (45 min) and hypoxia (2 and 4 h), respectively, using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Fluorescence-labelled cDNA probes were prepared using a SuperScript II reverse transcriptase kit (Invitrogen) in a total reaction volume of 30 ml. The reverse transcription mixture included 400 U Superscript RNase H-reverse transcriptase, 15 mM of each of dATP, dTTP, and dGTP, and 3 mM of Cy3-or Cy5-labelled cCTP. Cy3-and Cy5-labelled cDNAs were resuspended in 10 mL of a hybridization solution (GenoCheck, Seoul, Korea). After the two labelled cDNAs had been mixed, the mixture was denatured at 958C for 2 min and then incubated at 458C for 20 min. The expressions of 27 000 rat genes were then evaluated using OpArray Rat Genome microarrays (Operon Biotechnologies, Cologne, Germany). Hybridized slides were scanned with an Axon Instruments Gene-Pix 4000B scanner, and the images obtained were analysed using GenePix Pro 5.1 (Axon, Sunnyvale, CA, USA) and GeneSpring GX 7.3.1 (SilliconGenetics, Santa Clara, CA, USA). Only fold changes of two or more were considered in the analysis.
Real-time quantitative PCR analysis
Reaction mixtures (30 mL) consisted of 10 mL of Universal TaqMan Probe Master Mix (Applied Biosystems, Foster City, CA, USA), 1 mL of a 20Â mixture of forward and reverse primers, and TaqMan probes of DNA-damage-inducible transcript 4 (Ddit4), growth arrest and DNA damage-inducible 45 beta (Gadd45b), and activating transcription factor 3 (Atf3). The primers used for PCR were as follows: Ddit4, 5-CTA CTG ACC TGT TCG AGG CA-3 (sense) and 5-CCT CAC AGT TCA CTC CTC CA-5 (antisense); Gadd45b, 5-GTG TCA CCT CCG TCT TCT TG-3 (sense) and 5-GAT CCG AAC CCA AGA GGT AA-3 (antisense); Atf3, 5-CAT TGA AGT TGT CCA ATG GC-3 (sense) and 5-CAA CAC CAG GCT CAG AAA TG-3 (antisense); and Gapdh, 5-CCA TGG AGA AGG CTG GG-3 (sense) and 5-CAA AGT TGT CAT GGA TGA CC-3 (antisense).
Reverse transcriptase -PCR
Total RNA was isolated from cells, and cDNAs were synthesized using random hexamers and M-MLV reverse transcriptase (Invitrogen). The cDNAs obtained were then amplified by PCR using gene-specific primers for rat Ddit4, Gadd45b, Atf3, and Gapdh.
Western blot analysis
Western blot analysis was conducted as described previously. 10 After incubation with primary antibodies of anti-Ddit4, Gadd45b, Atf3, and actin (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and subsequently with secondary antibodies, bands were visualized using the NBT/BCIP method (Sigma-Aldrich, St Louis, MO, USA).
Transfection study in vitro
Small interfering RNAs (siRNA) of Ddit4 (#M-080119-00), Gadd45b (#L-100459-00), Atf3 (#M-080117-00), and scrambled siRNA (#D-001206-13-20) were obtained from the siGENOME SMARTpool of Dharmacon Research (Dharmacon RNA Technology, Lafayette, CO, USA). All siRNA oligonucleotides were resuspended in RNase-free water to a concentration of 20 mM. H9c2 cells were transiently transfected for 24 h with siRNAs targeting Ddit4, Gadd45b, and Atf3 using DharmaFECT 2 transfection reagent (both from Dharmacon RNA Technology). For gain-of-function study, H9c2 cells were transfected 24 h before experiments with either ectopic Gadd45b expression or empty vector (pcDNA3) using Lipofectin (Invitrogen) and after 24 h.
Immunocytochemistry
H9c2 cells were seeded on chamber slides, 4% paraformaldehyde (PFA)-fixed, treated with 0.1% Triton X-100 in PBS for 10 min, and incubated for 1 h with blocking solution at room temperature. Cells were then incubated for 2 h at room temperature with primary goat antibody against Gadd45b (1:100, Santa Cruz Biotechnology). An FITC-conjugated rabbit anti-goat IgG (1:400, Invitrogen) was used to visualize immunocomplexes under a fluorescence microscope. Nuclei were visualized using the fluorescent dye DAPI (Sigma, St Louis, MO, USA).
Tunel staining in H9c2 cells and heart tissues
In situ labelling of fragmented DNA was performed using the TUNEL assay using a commercially available Apop Tag Plus kit (Oncor, Gaithersburg, MD, USA), as described previously. 8 H9c2 cells were exposed to hypoxia for 6 or 8 h and hearts were excised from rats euthanized after 45 min of ischaemia and 24 h of reperfusion. 9 Then H9c2 cells and LVs were fixed with 4% PFA in PBS, and heart tissues were embedded in paraffin. Paraffin-embedded tissues were sectioned at 5 mM and used for TUNEL staining. The nuclei were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI, H9c2 cells) or haematoxyline (ventricular tissues). Percentage cell deaths were calculated by expressing numbers of TUNEL-positive cells as percentages of total cell counts.
Caspase-3 activity
After H9c2 cells had been exposed to 6 or 8 h of hypoxia, caspase-3 activity assays were performed, as described previously. 8 Briefly, extracted proteins were incubated with reaction buffer (100 mM HEPES, 10% sucrose, 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 10 mM DTT, and 10 mg/mL leupeptin) in a reaction volume of 100 mL containing 200 mM of Ac-DEVD-p-Na (Biomol, Plymouth Meeting, PA, USA). Enzyme-catalysed releases of p-nitroanilide were measured at 405 nm using a microplate reader (Molecular Devices, Palo Alto, CA, USA).
siRNA delivery in vivo
Chemically, synthetic siRNA against Gadd45b was synthesized by Dharmacon RNA Technology. The sequence of this prepared rat Gadd45b siRNA was 5-CGACAACGCGGUUCAGAAGUU-3 (sense) and 5-PCUUCUGAACCGCGUUGUCGUU-3 (antisense). A commercially available cationic polymer transfection reagent (in vivo-jetPEI; PolyPlus-Transfection, Illkirch, France) was used to deliver siRNA in a single intravenous (iv) injection. Briefly, 150 mg of siRNA was diluted into 200 mL of 5% glucose solution to get siRNA solution, and 24 mL of in vivo-jetPEI reagent was diluted into 200 mL of 5% glucose solution to get in vivo-jetPEI solution. The siRNA solution (200 mL) was then mixed with in vivo-jetPEI solution (200 mL), and the mixture obtained was incubated for 15 min at room temperature to allow the complexes to form. This mixture was then injected into a tail vein, as described by Sioud.
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The scrambled siRNA solution mixed with in vivo-jetPEI solution served as a siRNA control. Because the 3 days was found to be an optimum time point during preliminary experiments in which ventricular tissues were removed for reverse transcriptase (RT) -PCR and western blotting at various times (1, 2, 3, 4, and 5 days) after siRNA injection, the in vivo experiments were performed 3 days after siRNA injection. LVs were used for TUNEL assay or infarct size measurement and right ventricles were used for RT -PCR to assess siRNA transfection efficiency.
Immunohistochemistry
Rats were anaesthetized, and the ascending aorta was perfused with 0.9% saline, and then the heart was excised. Transversal sections of the LV were fixed with 4% PFA in PBS (pH 7.4) overnight at 48C, stored for 1 day at 48C in PBS containing 30% sucrose, and immersed in Tissue-Tek (Sakura Finetek, Tokyo, Japan). Tissues were then cryocut into 10 mm sections, which were mounted on silane-coated slides. Sections were then washed in PBS for 1 h, treated with 3% H 2 O 2 for 5 min (to deplete endogenous peroxidase), washed three times in PBS -T buffer (PBS containing 0.1% Triton X-100), blocked for 1 h in PBS-T containing 10% normal horse serum and 1% bovine serum albumin, and incubated overnight at 48C in a 1:50 dilution of primary goat polyclonal anti-Gadd45b (Santa Cruz Biotechnology). Sections were then washed four times in PBS-T buffer and stained with an ABC reagent of VECTASTAIN ABC kit (Vector, Burlingame, CA, USA) according to the manufacturer's instructions. The nuclei were counterstained with haematoxyline.
Haemodynamic measurements
Haemodynamic evaluations were performed with animals 3 days after iv injection with saline (control), scrambled siRNA, or Gadd45b siRNA, connected to the ventilator under anaesthesia, as mentioned above. A Millar pressure catheter (SPR-407, Millar Instruments, Houston, TX, USA) was inserted via the right carotid artery into the LV. 12 Blood pressure was measured using a data acquisition and analysis system (PowerLab 8s unit, AD Instruments, Mountain View, CA, USA). Heart rate (HR), LV systolic pressure (LVSP), LV end-diastolic pressure (LVEDP), and the rates of LV pressure rise and fall (LV dP/dt max and LV dP/dt min ) were recorded for 15 min for each animal using PowerLab V6.1.3 software (AD Instruments).
Determination of infarct size by triphenyltetrazolium chloride staining
To determine infarct sizes, rats were euthanized after 45 min of ischaemia and 90 min of reperfusion, as described previously. 8 Thereafter, the LAD was re-occluded and Evans Blue dye (1 mL of 2% w/v) was injected into the LV via the left femoral vein, to distinguish between perfused and nonperfused (area at risk, AAR) sections of the heart. The Evans Blue solution stains the perfused myocardium, while the occluded vascular bed remains uncoloured. 13 The left and right atria and right ventricle were then removed, and the obtained LV was rinsed of excess dye, and sliced transversely from apex to base into five 2 mm-thick sections, and then weighed. Colour digital images of both sides of each slice were obtained using a digital camera. To delineate infarct regions, the sections were incubated in 1% triphenyltetrazolium chloride (TTC, Sigma) in PBS (pH 7.4) at 378C for 20 min. Sections were then fixed in a 4% PFA solution and photographed using a digital camera. The regions stained blue (nonischaemic area), red (ischaemic but non-infarct area, AAR), and not stained (infract area) were outlined on each image and their areas were measured using Photoshop (Adobe Systems Inc., San Jose, CA, USA) and TINA software (Raytest, Straubenhardt, Germany). Percentage infarct sizes were calculated by expressing infarct areas as percentages of AAR.
Statistical analysis
Data are expressed as means + SDs for in vitro experiments and as means + SEMs for in vivo experiments. The Student's t-test was used to compare groups. Statistical significance was accepted for P-values of ,0.05.
Results
Microarray analysis
To assess gene profiling during ischaemia/hypoxia, microarray analysis was performed in hearts obtained from the in vivo transient ischaemia model (after 45 min of ischaemia), and from neonatal rat cardiomyocytes obtained from the in vitro hypoxia model. Analysis showed that 61 transcripts were up-regulated by more than two-fold in heart in vivo, and that 90 genes were up-regulated in cardiomyocytes in vitro. The up-regulated genes were classified into biological function groups, namely apoptosis, cell-cell signalling, cell cycle, cell differentiation, cell growth, cell proliferation, response to stress, signal transduction, transcription, and transport ( Figure 1A ). In addition, 22 and 247 transcripts were found to be down-regulated by ,0.5-fold in the in vivo and in vitro transient ischaemia models, respectively (data not shown). Because the goal of this study was to identify genes associated with ischaemia/hypoxia-induced apoptotic death, we focused on genes that were up-regulated during ischaemia/hypoxia. As shown in Figure 1B , DNA microarray analysis showed that the expressions of five genes, namely Ddit4, similar to hypothetical protein_predicted (RGD1562784_predicted), Gadd45b, Atf3, and SNF1-like kinase, were up-regulated by more than two-fold in both models. On the basis of the results of a literature search, Ddit4, Gadd45b, and Atf3 were selected as apoptosis-related genes, and their roles in ischaemia/hypoxia-induced apoptotic death were further examined.
Gadd45b as a novel mediator of cardiomyocyte apoptosis 
Inductions of Ddit4, Gadd45b, and Atf3 by ischaemia/hypoxia in vivo and in vitro
After 45 min of ischaemia in vivo, the mRNA and protein levels of Ddit4, Gadd45b, and Atf3 were found to be significantly up-regulated by more than two-fold by real-time PCR and western blotting (Figure 2A and C ) . These elevated levels of mRNA and protein were either further increased or maintained after 90 min of reperfusion following 45 min of ischaemia. In neonatal rat cardiomyocytes exposed to 2 or 4 h of hypoxia, the mRNA and protein levels of Ddit4, Gadd45b, and Atf3 were also increased by more than two-fold ( Figure 2B and D) .
Gadd45b-mediated apoptotic cardiomyocyte death during hypoxia
To assess the roles of the Ddit4, Gadd45b, and Atf3 genes in ischaemia/hypoxia-induced apoptotic cardiomyocyte death, loss-of-function and gain-of-function studies were performed in rat heart-derived H9c2 cells exposed to hypoxia. Figure 3A shows that the expressions of the mRNAs and proteins of Ddit4, Gadd45b, and Atf3 were suppressed in H9c2 cells transfected with their respective siRNAs. Maximum TUNEL-positivity was observed after 8 h of hypoxia (32.1 + 5.4 vs. 8.1 + 2.3% in the normoxic control; Figure 3B ), and this increase was dramatically blocked by transfection with Gadd45b siRNA (1.3 + 1.2%), but not by transfection with Ddit4 or Atf3 siRNA (36.5 + 2.3 and 28.1 + 5.2%, respectively). Similarly, maximum increase in caspase-3 activity was observed after 8 h of hypoxia (288.9 + 11.2% greater than that of the normoxic control; Figure 3C ). This increase was markedly inhibited by transfection with Gadd45b siRNA (155.6 + 13.4%), but not by transfection with Ddit4 or Atf3 siRNA (300.0 + 11.7 and 244.4 + 12.8%, respectively). As shown in Figure 4A and B, the expression of Gadd45b was increased remarkably not only after 4 or 6 h of hypoxia, but also after the ectopic transfection of Gadd45b. Under normoxic conditions, the increased expression of Gadd45b protein by ectopic transfection did not significantly affect either TUNEL-positivity ( Figure 4C ) or caspase-3 activity ( Figure 4D) . However, after 6 h of hypoxia, TUNELpositivity (25.1 + 4.2%) and caspase-3 activity (257.7 + 7.4%) were far greater in cells transfected with ectopic Gadd45b than in cells transfected with pcDNA (7.2 + 1.5 and 143.3 + 6.7%, respectively; Figure 4C and D). These results indicate that the level of Gadd45b at baseline does not contribute to the induction of apoptosis under normoxic conditions, but rather that it may determine whether apoptosis is initiated after exposure to hypoxia. However, Gadd45b overexpression had little effect on cell death after 8 h of hypoxia, presumably because Gadd45b as a novel mediator of cardiomyocyte apoptosis TUNEL-positivity and caspase-3 activity peaked after 8 h of hypoxia, after which cells became detached.
Pre-ischaemic haemodynamic parameters after the knockdown of gadd45b
Haemodynamic analysis was performed before MI surgery to assess LV function. The haemodynamic parameters measured are summarized in Table 1 . No significant differences were observed between the HRs of animals in the control, scrambled siRNA, and Gadd45b siRNA groups (405 + 9, 403 + 11, and 422 + 8 b.p.m., respectively). In addition, LVSP and LV dP/dt max (indices of LV systolic function) of the control were not significantly changed by either scrambled siRNA or Gadd45b siRNA transfection. Furthermore, LVEDP and LV dP/dt min (indices of LV diastolic function) in the control group were not significantly different from those of the scrambled siRNA and Gadd45b siRNA groups. These results indicate that LV function was not altered by injecting scrambled siRNA or Gadd45b siRNA into the control rat.
Knockdown of Gadd45b protected rats against ischaemic heart injury
To confirm the roles of the Gadd45b gene in ischaemia/hypoxiainduced apoptotic cardiomyocyte death in vivo, a loss-of-function study was performed. As an in vivo model, we used a rat model of Haemodynamic evaluations were performed with animals 3 days after iv injection with saline (Control), scrambled siRNA, or Gadd45b siRNA. Data shown are means + SEM (n ¼ 6 -8).
No differences were found between the groups (n.s., not significant). LV, left ventricle; LVSP, maximum left ventricular systolic pressure; LVEDP, left ventricular end-diastolic pressure; dP/dt max , the steepest slope during the upstroke of the pressure curve; dP/dt min , the steepest slope during the downstroke of the pressure curve.
45 min of ischaemia/90 min of reperfusion, instead of a 45 minischaemia model, due to previous reports that reperfusion accelerates the apoptotic process triggered by ischaemia. 14 In hearts from Gadd45b siRNA-transfected rats, the mRNA and protein levels of Gadd45b were remarkably decreased in a time-dependent manner.
As shown in Figure 5A , the mRNA and protein expressions of Gadd45b in LVs began to decrease 2 days after Gadd45b siRNA injection and reduced up to ca. 60% in both mRNA and protein expressions. The down-regulations of Gadd45b mRNA and protein peaked at 3 days (38 + 4.1 and 48 + 5.4%, respectively), started to recover at 5 days (75 + 3.0% for mRNA and 83 + 4.7% for protein). On the basis of these results, the optimum time point after siRNA injection was deemed to be 3 days. Because similar results were observed in right ventricles (data not shown), they were used for RT-PCR in each in vivo experiment to confirm the transfection efficiency of siRNA. As shown in Figure 5B , immunohistochemical Gadd45b staining of fresh frozen heart tissues demonstrated a basal level expression of Gadd45b with cytoplasmic and nuclear staining in cardiomyocytes, and further confirmed a significant reduction in Gadd45b immunoreactivity 3 days after Gadd45b siRNA injection. Figure 5C shows that the mean TUNEL-positivity of hearts (LVs) from scrambled siRNA-transfected rats (25.5 + 1.2%) was significantly reduced in hearts from Gadd45b siRNA-transfected rats (3.9 + 1.2%). Furthermore, the percentage of infarct size of scrambled siRNA group (55.8 + 3.9%) was also significantly reduced in Gadd45b siRNA group (36.7 + 4.4%) as shown in Figure 5D .
Discussion
This study demonstrated that Gadd45b plays an essential role in the apoptotic death of cardiomyocytes during ischaemic/hypoxic injury. The apoptosis of cardiomyocytes is known to be causally associated with the acute and chronic phases of ischaemic heart diseases. 15, 16 Animal studies have shown that the inhibition of apoptosis has a beneficial effect on the disease process. Although various animal and human studies have sought to elucidate the Gadd45b as a novel mediator of cardiomyocyte apoptosis molecular basis of ischaemic heart injury, the genes responsible for the ischaemia/hypoxia-induced apoptotic death of cardiomyocytes have not been identified. The results of this study demonstrate that Gadd45b plays an essential role in ischaemia/hypoxia-induced apoptotic cardiomyocyte death based on the following evidence. First, the mRNA and protein levels of Gadd45b were significantly increased by transient ischaemia/hypoxia in heart tissues in vivo and in cardiomyocytes in vitro. Secondly, ischaemia/hypoxia-induced apoptotic cardiomyocyte death was remarkably attenuated by the down-regulation of Gadd45b in both the in vivo and in vitro ischaemia models. Finally, hypoxia-induced apoptotic death was aggravated by the ectopic expression of Gadd45b in H9c2 cells. Notably, this study also shows that an increase in the level of Gadd45b protein per se does not contribute to the apoptosis of cardiomyocytes under normoxic condition, but that it aggravates apoptosis after exposure to hypoxia. These results suggest that increased Gadd45b expression may not be sufficient, but is nevertheless essential for the induction of the apoptotic death of cardiomyocytes in response to hypoxia. Gadd45a, Gadd45b and Gadd45g constitute the Gadd45 family. Gadd45b is expressed ubiquitously in mammalian tissues, is responsive to stimuli that induce DNA damage, and was initially recognized as a transcript that is rapidly induced in response to transforming growth factor (TGF)-b treatment or during the onset of the terminal differentiation of M1 murine myeloid cells. 17, 18 Subsequent studies that employed antisense-mediated silencing established that Gadd45b is an important regulator of the G 2 /M checkpoint following genotoxic stress. 19 Consistent with our findings regarding the pro-apoptotic role of Gadd45b, it has been reported to participate causatively in TGF-b-dependent apoptosis in murine hepatocytes. 20 In addition, the overexpression of Gadd45b in ML-1 and HeLa cells was found to induce apoptosis. 21 In contrast, however, the overexpression of Gadd45b has been found to suppress apoptotic death in other cell types, such as NIH3T3 and INS-1Eb cells. 22, 23 Accordingly, the role of Gadd45b in apoptosis appears to be cell-type-specific. p38 activation has been suggested to be required for Gadd45b-mediated apoptotic cell death in murine hepatocytes. 20 In addition, p38 and JNK have been reported to be involved downstream of Gadd45b apoptotic signalling in HeLa cells. 21 Previously, we demonstrated that the activation of p38 is critically involved in apoptotic cardiomyocyte death induced by hypoxia. 24 On the basis of these findings, it appears that p38 is involved in the Gadd45b apoptotic signalling pathways. Further work is needed to elucidate the mechanisms whereby Gadd45b causes cardiomyocyte apoptosis.
In summary, this study shows that Gadd45b is a critical mediator of ischaemia/hypoxia-induced apoptotic death in cardiomyocytes, and our findings suggest that strategies targeting Gadd45b could be used to inhibit apoptotic cell death during ischaemic heart injury.
